Sharof M. Tugizov, DVM, PhD, DSc

Professor, Department of Medicine, UCSF

sharof.tugizov@ucsf.edu

Phone: (415) 514-3177 (voice)
Box 0512, UCSF
San Francisco, CA 94143-0512

View on UCSF Profiles

Additional Websites

• Department of Infectious Diseases

Education

Institute of Agriculture, School of Veterinary Medicine, Samarkand, Uzbekistan (former Soviet Union), DVM 1981, Veterinary Medicine
Institute of Experimental Veterinary Medicine and Ivanosky Institute of Virology, Moscow, Russia, PhD, 1985, Virology, Cell Biology
Ivanosky Institute of Virology, Russian Academy of Medical Sciences, Moscow, Russia, DSc, 1996, Medical Virology Infectious Disease

Professional Experience

• 1985-88
  Junior Research Scientist, Dept. of Virus Physiology, Ivanovsky Institute of Virology, Academy of Medical Sciences, Moscow, USSR
• 1988-91
  Senior Research Scientist, Dept. of Molecular Biology, Ivanovsky Institute of Virology, Academy of Medical Sciences, Moscow, USSR
• 1991-94
  Visiting Scientist, Department of Stomatology, School of Dentistry, University of California, San Francisco, California
• 1994-99
  Researcher in Virology and Molecular Biology, Department of Stomatology, School of Dentistry, University of California, San Francisco, California
• 1999-2005
  Assistant Adjunct Professor, Department of Medicine, School of Medicine, University of California, San Francisco, California
• 2005-11
  Associate Professor, Department of Medicine, School of Medicine, University of California, San Francisco, California
• 2011-current
  Professor, Department of Medicine, School of Medicine, University of California, San Francisco, California

Honors & Awards

• 2001 Hellman Fellow
• Ad hoc reviewer for NIH, USA, 2006
• Ad hoc reviewer for NIH, USA, 2009
• Ad hoc reviewer for Cancer Research Institute, United Kingdom, 2002
• Ad hoc reviewer for Cancer Research Institute, United Kingdom, 2006
• Ad hoc reviewer for Cancer Research Institute, United Kingdom, 2009
• Ad hoc reviewer for Hellman Family Foundation, 2010
• Ad hoc referee for Journal of Virology, Journal of Dermatology, In vitro, Journal of Oral Pathology and Medicine, Voprosi Virusologii (in Russian), British Journal of Dermatology, Plos Pathogens, Virology, Journal of Dental Research, Chemotherapy, AIDS, Viral Immunology
• Member of Editorial Board, Virology& Mycology

Selected Publications

1. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. J Virol. 2012 Mar; 86(5):2556-70.
   View on PubMed
2. Challacombe SJ, Fidel PL, Tugizov S, Tao L, Wahl SM. HIV infection and specific mucosal immunity: workshop 4B. Adv Dent Res. 2011 Apr; 23(1):142-51.
   View on PubMed
3. Tugizov SM, Webster-Cyriaque JY, Syrianen S, Chattopadyay A, Sroussi H, Zhang L, Kaushal A. Mechanisms of viral infections associated with HIV: workshop 2B. Adv Dent Res. 2011 Apr; 23(1):130-6.
   View on PubMed
4. Weinberg A, Naglik JR, Kohli A, Tugizov SM, Fidel PL, Liu Y, Herzberg M. Innate immunity including epithelial and nonspecific host factors: workshop 1B. Adv Dent Res. 2011 Apr; 23(1):122-9.
   View on PubMed
5. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology. 2011 Jan 20; 409(2):211-22.
   View on PubMed
6. Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, Weber M, Byland R, Bernasconi M, Berger C, Tugizov S, Speck RF, Nadal D. beta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection. J Virol. 2010 Jul; 84(13):6667-77.
   View on PubMed
7. Xiao J, Palefsky JM, Herrera R, Sunshine C, Tugizov SM. EBV-positive human sera contain antibodies against the EBV BMRF-2 protein. Virology. 2009 Oct 10; 393(1):151-9.
   View on PubMed
8. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells. Virology. 2009 Jun 5; 388(2):335-43.
   View on PubMed
9. Haga T, Uchide N, Tugizov S, Palefsky JM. Role of E-cadherin in the induction of apoptosis of HPV16-positive CaSki cervical cancer cells during multicellular tumor spheroid formation. Apoptosis. 2008 Jan; 13(1):97-108.
   View on PubMed
10. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells. Virology. 2008 Jan 20; 370(2):430-42.
    View on PubMed
11. Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, Palefsky JM. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol. 2007 Jun; 81(11):5484-96.
    View on PubMed
12. Xiao J, Palefsky JM, Herrera R, Tugizov SM. Characterization of the Epstein-Barr virus glycoprotein BMRF-2. Virology. 2007 Mar 15; 359(2):382-96.
    View on PubMed
13. Tugizov S, Berline J, Herrera R, Penaranda ME, Nakagawa M, Palefsky J. Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex. J Virol. 2005 Jan; 79(2):1099-112.
    View on PubMed
14. Tugizov SM, Berline JW, Palefsky JM. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med. 2003 Mar; 9(3):307-14.
    View on PubMed
15. Tugizov S, Maidji E, Xiao J, Pereira L. An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol. 1999 Oct; 73(10):8677-88.
    View on PubMed
16. Tugizov S, Maidji E, Xiao J, Zheng Z, Pereira L. Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells. J Virol. 1998 Sep; 72(9):7374-86.
    View on PubMed
17. Maidji E, Tugizov S, Abenes G, Jones T, Pereira L. A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F-actin. J Virol. 1998 Jul; 72(7):5717-27.
    View on PubMed
18. Navarro D, Lennette E, Tugizov S, Pereira L. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J Med Virol. 1997 Aug; 52(4):451-9.
    View on PubMed
19. Maidji E, Tugizov S, Jones T, Zheng Z, Pereira L. Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J Virol. 1996 Dec; 70(12):8402-10.
    View on PubMed
20. Zheng Z, Maidji E, Tugizov S, Pereira L. Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding. J Virol. 1996 Nov; 70(11):8029-40.
    View on PubMed

View on UCSF Profiles